Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 1:55 PM
Ignite Modification Date:
2025-12-25 @ 12:44 PM
NCT ID:
NCT02784795
Pre Assignment Details:
The study consists of 5 separate, parallel dose escalations (dose esc) followed by dose-confirmation (dose conf) study parts (Part A - E). LY3039478 is given in combination with taladegib for Part A, LY3023414 for Part B, abemaciclib (abema) for Part C, cisplatin (cis) and gemcitabine (gem) for Part C, and gemcitabine and carboplatin (carb) for Part E. A participant completed the study if they completed at least 1 cycle (1 cycle = 28 days for Part A, B and C and 21 days for Part D, E) .
Study:
NCT02784795
Study Brief:
Results Section:
NCT02784795